Hand holding the newspaper resting on a table with a cup of coffee

Newsroom

Taxonomy Icon
  • November 28, 2018
  • Source: Texoma's | KFDX 3
Senator John McCain recently died after fighting glioblastoma, the most aggressive and deadliest kind of brain tumor. Now, other patients whose brain tumors come back have a revolutionary new option for treatment.
Taxonomy Icon
  • November 27, 2018
A new Ivy Brain Tumor Center study finds that recently-approved drug ribociclib may be an important part of treatment for glioblastoma, one of the deadliest cancers in the world.
Taxonomy Icon
  • November 25, 2018
  • Source: The ASCO Post
The Ben and Catherine Ivy Foundation, in partnership with the Barrow Neurological Institute in Phoenix, has awarded a $50 million grant to establish a new translational science program focusing on early-phase, pharmacodynamic- and pharmacokinetic-driven clinical trials for aggressive brain tumors.
Taxonomy Icon
  • November 8, 2018
  • Source: WNDU | 16 News Now
In the last 30 years, a brain tumor expert says median survival has only increased by a few months. Now, a new brain tumor center program is fast-tracking patients into new therapies.
Taxonomy Icon
  • September 10, 2018
  • Source: Phoenix Business Journal
Thanks to a $50 million grant, Barrow Neurological Institute will create a new center to focus on finding a cure and improving outcomes for the deadliest form of brain cancer.
Taxonomy Icon
  • September 10, 2018
  • Source: Arizona Republic
With $50 million from a private foundation, Phoenix-based Barrow Neurological Institute announced Monday that it is opening a center to focus on improving brain-cancer outcomes through experimental clinical trials.
Taxonomy Icon
  • August 26, 2018
  • Source: WKYC Studios
Barrow Neurological Institute, has launched a “phase zero” study that aims to rapidly test drugs on patients whose brain cancer tumors have returned after standard treatment.